10-Q: Standex Q1 Earnings Fall Despite Revenue Surge

Standex International reports a 27.6% revenue increase driven by acquisitions, but net income and EPS decline due to higher interest and restructuring costs.

Summary

• Net sales for the first quarter of fiscal year 2026 increased by $47.0 million, or 27.6%, to $217.4 million compared to $170.5 million in the prior year quarter.
• Acquisitions contributed $45.3 million (26.6%) to the sales increase, while organic sales grew by $1.0 million (0.6%).
• Gross profit margin improved to 41.6% from 41.1% in the prior year quarter.
• Income from operations increased by $5.5 million, or 23.0%, to $29.6 million.
• Net income attributable to Standex International Corporation decreased by 17.26% to $15.056 million from $18.197 million.
• Diluted earnings per share from continuing operations decreased to $1.25 from $1.53.
• Interest expense significantly increased to $8.9 million from $0.977 million in the prior year quarter.
• Restructuring costs rose to $6.0 million from $1.1 million in the prior year quarter, primarily due to facility rationalizations and four Engraving site closures.
• Total backlog increased by 46.2% to $302.5 million, with backlog under one year rising 37.8% to $246.3 million, largely driven by acquisitions.
• Cash and cash equivalents decreased to $98.7 million at September 30, 2025, from $104.5 million at June 30, 2025.
• Net cash used in financing activities increased to $15.5 million from $6.3 million in the prior year quarter, primarily due to debt payments, dividends, and treasury stock purchases.
• The company acquired McStarlite for $57.0 million on February 5, 2025, and the Amran/Narayan Group for $434.4 million on October 28, 2024.

Sentiment

Score: 4

Explanation: While revenue and operating income saw significant increases, largely due to recent acquisitions, net income and EPS declined substantially year-over-year. This was primarily driven by a sharp rise in interest expense and restructuring costs. Organic growth was modest overall, with some segments experiencing declines. The company faces ongoing challenges from tariffs, inflation, and specific market downturns.

Positives

• Net sales increased significantly by 27.6% to $217.4 million, primarily driven by strategic acquisitions.
• Gross profit margin improved to 41.6% from 41.1%, reflecting portfolio evolution and pricing discipline.
• Income from operations grew by 23.0% to $29.6 million, benefiting from acquisitions and productivity initiatives.
• Total backlog surged by 46.2% to $302.5 million, indicating strong future demand, with backlog under one year up 37.8%.
• The Electronics segment reported robust sales growth of 42.2% and a 66.1% increase in operating income, with an improved operating margin of 25.6%.
• The Engineering Technologies segment achieved 12.7% organic sales growth, driven by space and aviation end markets.
• The Engraving segment saw 5.6% organic sales growth and a 12.2% increase in operating income, with an improved operating margin of 18.2%.
• The company remains compliant with its financial covenants, with an Interest Coverage Ratio of 4.62:1 (minimum 2.75:1) and a Leverage Ratio of 2.62:1 (maximum 3.5:1).
• A stock buyback program is active, with $24.072 million remaining authorization, and the company repurchased 17,792 shares in the quarter.
• Dividends declared increased to $0.32 per share from $0.30 per share in the prior year quarter.

Negatives

• Net income attributable to Standex International Corporation decreased by 17.26% to $15.056 million.
• Diluted earnings per share from continuing operations decreased to $1.25 from $1.53.
• Interest expense increased dramatically to $8.9 million from $0.977 million, significantly impacting profitability.
• Restructuring costs increased sharply to $6.0 million from $1.1 million, reflecting ongoing operational adjustments.
• Cash and cash equivalents decreased by $5.9 million during the quarter.
• Net cash used in financing activities more than doubled to $15.5 million from $6.3 million.
• The Engineering Technologies segment's operating income decreased by 9.8% due to purchase accounting expenses and project timing related to the McStarlite acquisition.
• The Scientific segment experienced an 8.7% organic sales decline due to lower demand from academic and research institutions impacted by NIH funding cuts.
• The Specialty Solutions segment's operating income decreased by 18.6% due to higher tariff costs.
• Organic sales in the Electronics segment decreased by 3.1% due to the timing of backlog conversion in the Magnetics business in North America.
• Foreign currency translation adjustments resulted in a significant loss of $15.273 million in other comprehensive income.

Risks

• Materially adverse or unanticipated legal judgments, fines, penalties, or settlements.
• Conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash.
• Domestic and international economic conditions, including the impact, length, and degree of economic downturns on served markets (e.g., automotive, construction, aerospace, defense).
• Lower-cost competition impacting market share and profitability.
• The relative mix of products affecting margins and operating efficiencies in certain businesses.
• Impact of higher raw material and component costs, particularly steel, certain electronics parts materials, petroleum-based products, and refrigeration components.
• Impact of higher transportation and logistics costs, especially for goods from Asia.
• Impact of inflation on the costs of providing products and services, including wages, benefits, and medical costs.
• Inability to realize expected cost savings from restructuring activities, including plant consolidations and productivity enhancements.
• Potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or do not meet growth and return expectations.
• Inability to achieve savings expected from global sourcing of raw materials and diversification efforts in emerging markets.
• Impact on cost structure and economic conditions due to actual and potential increases in trade tariffs.
• Inability to attain expected benefits from acquisitions and effectively consummate and integrate them, including achieving envisioned synergies.
• Increased costs from acquisitions to improve and coordinate managerial, operational, financial, and administrative systems, including internal controls and Sarbanes-Oxley compliance.
• Market acceptance of new products and the ability to design, introduce, and sell them.
• Ability to redesign products to meet evolving regulatory requirements.
• Impact of delays initiated by customers.
• Ability to increase manufacturing production to meet demand, including as a result of labor shortages.
• Impact on operations from any successful cybersecurity attacks.
• Potential changes to future pension funding requirements.
• Exposure to foreign currency exchange rate fluctuations (transactional and translation risk) for currencies like the Euro, British Pound Sterling, Japanese Yen, Peso, Chinese Yuan, and Indian Rupee.
• Interest rate risk on variable rate borrowings, partially mitigated by interest rate swaps.
• Exposure to fluctuating market prices for commodities used in manufacturing processes, such as rhodium, steel, and other metal commodities.
• Potential supply shortages for raw materials.

Future Outlook

Management anticipates continued improvement in key financial metrics for the remainder of fiscal year 2026, supported by productivity initiatives. They expect continued growth in the high-margin electrical grid market through the integration of the Amran/Narayan Group, with space and defense end markets remaining strong. Stability is projected for hybrid and electric vehicle programs, refuse and dump, and food service equipment markets. However, scientific cold storage demand is expected to decline due to NIH funding cuts. The company also forecasts growth from new product sales and expects to realize benefits from restructuring actions in the second half of fiscal year 2026. Fiscal year 2026 capital spending is projected between $33.0 million and $38.0 million, with depreciation between $24.0 million and $26.0 million and amortization between $15.5 million and $17.5 million.

Management Comments

• "Our long-term business strategy is to create, improve, and enhance shareholder value by building more profitable, focused industrial platforms through our Standex Value Creation System."
• "We intend to continue investing organically and inorganically in high margin and growth businesses using this balanced and proven approach."
• "We continue to execute on acquisitions where strategically aligned with our businesses and where the opportunity meets our investment metrics."
• "As a result of our portfolio moves over the past several years, we have transformed Standex to a company with a more focused group of businesses selling customized solutions to high value end markets via a compelling customer value proposition."
• "We expect to start seeing realization of these restructuring actions during the second half of fiscal year 2026."
• "We anticipate continued improvement in key financials metrics, supported by productivity initiatives."
• "We plan to continue to invest in our key strategic growth priorities while closely managing our cost structure and driving productivity and pricing actions and seeking alternate sources of supply to further reduce the impact of tariffs as appropriate."
• "To the best of our knowledge, we believe that we are presently in substantial compliance with all existing applicable environmental laws and regulations and do not anticipate any instances of non-compliance that will have a material effect on our future capital expenditures, earnings or competitive position."

Industry Context

The company operates across diverse industrial markets, including electrical grid, aerospace, defense, automotive (hybrid/EV), scientific cold storage, refuse and dump, and food service equipment. Its strategy emphasizes focusing on higher-margin segments and faster-growing markets, such as the electrical grid market through recent acquisitions. The scientific segment is experiencing headwinds from NIH funding cuts, while space and defense markets show continued strength. The company acknowledges challenges from lower-cost competition, rising raw material costs, transportation expenses, and inflation, which are common industry-wide pressures.

Legal Proceedings

• The company is subject to various claims and legal proceedings, including environmental remediation claims, arising in the ordinary course of business. Management does not believe the outcome of currently existing legal matters will have a material impact on the company's consolidated financial position, results of operations, or cash flow.

Related Party Transactions

• The company has a redeemable noncontrolling interest representing 9.9% of Narayan Powertech Private Limited, which is subject to a Shareholder Agreement providing put rights to the noncontrolling interest holders and a future acquisition right for Mold-Tech Singapore.

Stakeholder Impact

• Shareholders: Experienced a decrease in net income and EPS, but benefited from an increased dividend and ongoing share buyback program. Future growth is anticipated from strategic acquisitions and productivity initiatives.
• Employees: Restructuring initiatives involve severance and headcount reductions, particularly in the Engraving segment. Corporate expenses increased due to variable compensation and employee medical costs.
• Customers: Demand is strong in space, defense, aviation, and European Engraving markets, but lower in scientific cold storage (due to NIH funding cuts) and North American Magnetics. The company focuses on customized solutions.
• Suppliers: The company is exposed to fluctuating raw material costs and potential supply shortages, actively seeking alternate sources to mitigate tariff impacts.
• Creditors: The company maintains compliance with debt covenants, but faced a significant increase in interest expense due to higher borrowing rates.

Next Steps

• Complete 2026 restructuring activities by fiscal year 2027.
• Complete prior year restructuring activities by fiscal year 2026.
• Continue to evaluate the impact of the 'One Big Beautiful Bill Act of 2025' tax law changes on financial statements.
• Evaluate the impact of ASU 2025-05 (Credit Losses for Accounts Receivable) on consolidated financial statements.
• Evaluate the effects of ASU 2025-06 (Internal-Use Software) on consolidated financial statements.
• Seek regulatory approval from the Reserve Bank of India (RBI) for the acquisition of the remaining 9.9% of Narayan Powertech Private Limited.
• Continue investing organically and inorganically in high-margin and growth businesses.
• Continue to divest businesses that are not strategic or do not meet growth and return expectations.
• Monitor inflationary rates and make adjustments to reserves as deemed necessary.
• Implement price increases to offset the impact of changing raw material costs wherever possible.
• Seek alternate sources of supply to further reduce the impact of tariffs as appropriate.
• The next measurement date for U.S. defined benefit pension plan assets and benefit obligations will be on June 30, 2026.
• Expect approximately $1.5 million in restructuring expense for the remainder of fiscal year 2026.
• Expect fiscal year 2026 capital spending to be between $33.0 million and $38.0 million.
• Expect fiscal year 2026 depreciation expense to be between $24.0 million and $26.0 million.
• Expect fiscal year 2026 amortization expense to be between $15.5 million and $17.5 million.
• Expect to pay $5.7 million in contributions to defined benefit plans during the remainder of fiscal year 2026.

Key Dates

Recommendation

While Standex International Corporation demonstrated strong top-line growth driven by strategic acquisitions, the significant decline in net income and diluted EPS is a concern. The substantial increase in interest expense and restructuring costs weighed heavily on profitability. The mixed organic growth across segments, with some experiencing declines due to market-specific challenges like NIH funding cuts, indicates underlying pressures. The company's strong backlog and strategic focus on high-margin markets are positive, but the immediate profitability headwinds suggest a cautious approach. Investors should monitor the realization of expected cost savings from restructuring and the integration of acquisitions, as well as the impact of ongoing macroeconomic factors like tariffs and inflation, before considering further investment.

Keywords

Diversified Industrial Manufacturer, Electronics, Engineering Technologies, Scientific, Engraving, Specialty Solutions, Acquisitions, Restructuring, SEC Filing, Quarterly Report, Financial Performance, Backlog, Capital Allocation, Supply Chain, Tariffs, Inflation, Interest Rates, Aerospace Components, Instrument Transformers, Cold Storage Equipment, Mold Texturing, Hydraulic Cylinders, Merchandising Displays